BIIB129
BIIB129 is a brain-penetrant, covalent BTK inhibitor used for research into B-cell driven pathologies. It is employed in both in vitro and in vivo studies to investigate mechanisms of B-cell proliferation and related autoimmune or oncological diseases.
Product Specifications
CAS Number
2770960-52-4
Product Name Alternative
BIIB 129
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.56% (May vary between batches)
Solubility
DMSO:80 mg/mL (218.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (9.01 mM)
Smiles
O (C=1C=2N (C=C (N1) C3=CN (C) N=C3) N=CC2) [C@@]4 (C) C[C@@H] (N (C (C=C) =O) C) C4
Molecular Formula
C19H22N6O2
Molecular Weight
366.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6475232-01 0.1 mL
EIF2AK3, CT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 3, PRKR-like Endoplasmic Reticulum Kinase, Pancreatic eIF2-alpha Kinase, HsPEK, PEK, PERK) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6475232-02 5x 0.1 mL
EIF2AK3, CT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 3, PRKR-like Endoplasmic Reticulum Kinase, Pancreatic eIF2-alpha Kinase, HsPEK, PEK, PERK) (MaxLight 750)
Sign In for Pricing
View Details MBS1266226-01 0.01 mg Plasmid + 0.2 mL Glycerol-Stock
WISP2 cDNA Clone
Sign In for Pricing
View Details